Vanderbilt-Ingram Cancer Center launched My Cancer Genome (MCG) in January 2011 to help physicians and researchers track the latest developments in precision cancer medicine and connect them with clinical research trials. In 2013, GenomOncology became the exclusive commercial partner of MCG. MCG is powered by the GenomOncology Knowledge Management System (KMS) and the content created by its curation team including biomarker-driven therapies, prognoses, and clinical trials is available through GenomOncology solutions.
Chad Shaw, Ph.D – Baylor Genetics Diagnostic Labs Associate Professor Molecular and Human Genetics, Baylor College of Medicine
In 2018, GenomOncology collaborated with UNMC to develop a proprietary solution called GO Connect, a software that integrates with current EHRs by generating standard HL7 messages to describe somatic mutations.READ MORE